Riskpilot← Back to searchSign inGet full accessGREINDX AS
ASActiveOrg 921835876Forskningsparken I Oslo Gaustadalléen 21, 0349 OsloEngineering activities and related technical consultancy · NACE 7112Est. 20183 employeeswww.greindx.com
Revenue 2024
NOK 1,6M
-59% vs 2023
EBITDA margin
-229.3%
-5% vs 2023
Equity ratio
20.8%
Financial strength
Net profit 2024
NOK -2,9M
-32% vs 2023
| Revenue | NOK 1,6M | -59% |
| EBITDA | NOK -3,8M | -5% |
| Net profit | NOK -2,9M | -32% |
| Total assets | NOK 2,6M | -7% |
| Equity | NOK 545K | -84% |
| Employees | 3 | — |
Legal name
GREINDX AS
Org number
921835876
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
5. desember 2018
Share capital
NOK 119 638
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Utvikle ny teknologi og nye produkter for forsknings og diagnostisk bruk innen human og veterinær området.
Address
Forskningsparken I Oslo Gaustadalléen 21, 0349 Oslo
Website
www.greindx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 100 | 450 | 1 074 | 3 334 | 3 967 | 1 638 |
| Staff expenses | −0 | −0 | −277 | −1 967 | −2 788 | −2 670 |
| EBITDA | −256 | −104 | −1 066 | −3 048 | −3 575 | −3 757 |
| Depreciation & amort. | −0 | −0 | −0 | −72 | −119 | −124 |
| EBIT | −256 | −104 | −1 066 | −3 120 | −3 694 | −3 880 |
| Net financials | −8 | −243 | 383 | 1 151 | 1 522 | 1 016 |
| Profit before tax | −263 | −346 | −683 | −1 969 | −2 172 | −2 865 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −263 | −346 | −683 | −1 969 | −2 172 | −2 865 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 501 | 201 | 7 858 | 5 955 | 2 818 | 2 618 |
| Equity | 271 | 213 | 7 466 | 5 585 | 3 413 | 545 |
| Long-term debt | 0 | 9 | 0 | 0 | 0 | 2 336 |
| Short-term debt | 229 | −21 | 392 | 370 | −595 | −263 |
| Total debt | 229 | −13 | 392 | 370 | −595 | 2 073 |
EBITDA margin
-229.3%
This company
15.8%
Market median
-1551% vs market
20192024
Equity ratio
20.8%
This company
38.2%
Market median
-46% vs market
20192024
Return on equity
-525.2%
This company
18.4%
Market median
-2954% vs market
20192024
Net profit margin
-174.9%
This company
8.1%
Market median
-2259% vs market
20192024
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
20192024
Debt / equity
3.80×
This company
0.62×
Market median
-513% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-10-08 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Px3 Diagnostics As | Company | 31.4% | 31.4% | 2024 |
Amir Lichtenstein | Company | 18.6% | 18.6% | 2024 |
Hem Bollingmo Holding As | Company | 16.7% | 16.7% | 2024 |
Symthera Canada Ltd | Company | 9.3% | 9.3% | 2024 |
Medical Technology Llc | Company | 4.5% | 4.5% | 2024 |
| Individual | 4.2% | 4.2% | 2022 | |
Greindx As | Company | 3.2% | 3.2% | 2024 |
Luke Saban | Company | 2.3% | 2.3% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GREINDX AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Petter Ottersen | Board of Directors | 0 companies |
| Ole Jesper Dahlberg | Board of Directors | 0 companies |
| Ove Vincent Solesvik | Chairman | 0 companies |
| Christian Fredrik Stray | Board of Directors | 0 companies |
| Amir Lichtenstein | Board of Directors | 0 companies |